James T Frix

US Patent:

20160228044, Aug 11, 2016

Filed:

Apr 19, 2016

Appl. No.:

15/132744

Inventors:

JAMES TYLER FRIX - CALHOUN GA, US
ANDREW JOHNSON - ATHENS GA, US
JAMES MITCHELL FRIX - CALHOUN GA, US
ROBERT ANDREW TAYLOR - ANDERSON SC, US

International Classification:

A61B 5/1455
A61B 5/0205
A61B 5/00

Abstract:

Various embodiments of methods and systems for continuous transdermal monitoring (“CTM”) are disclosed. One exemplary embodiment of a continuous transdermal monitoring system comprises a sensor package. The sensor package may include a pulse oximetry sensor having a plurality of light detectors arranged as an array. One exemplary method for continuous transdermal monitoring begins by positioning a pulse oximetry sensor system, similar to the system described immediately above, adjacent to a target tissue segment. Then, the method continues by detecting a light reflected by the target tissue segment. Then, the method continues by transmitting a pulse oximetry reading(s), based at least in part on the light reflected by the target tissue segment, of the target tissue segment. Then, the method continues by analyzing the pulse oximetry reading(s). Then, the method continues by assessing the accuracy of the pulse oximetry reading from the first light detector relative to the pulse oximetry reading from the second light detector.

US Patent:

20160228065, Aug 11, 2016

Filed:

Apr 18, 2016

Appl. No.:

15/131130

Inventors:

JAMES TYLER FRIX - CALHOUN GA, US
ANDREW JOHNSON - ATHENS GA, US
JAMES MITCHELL FRIX - CALHOUN GA, US
ROBERT ANDREW TAYLOR - ANDERSON SC, US

International Classification:

A61B 5/00
A61B 5/1455

Abstract:

Various embodiments of methods and systems for continuous transdermal monitoring (“CTM”) are disclosed. One exemplary method for CTM begins by monitoring an output signal from an accelerometer. The accelerometer output signal may indicate acceleration and deceleration of a body part of a user, such as the user's wrist. Based on the accelerometer output signal, it may be determined that the body part of the user has decelerated to a minimum, e.g., substantially zero. With a determination that the body part has decelerated to the minimum, e.g., substantially zero, or has not accelerated beyond the minimum, e.g., substantially zero, the method may determine a reading from a pulse oximeter associated with the accelerometer. Advantageously, the pulse oximetry reading, or a reading from other sensors associated with the accelerometer, may be optimally accurate as motion artifact may be minimized. The pulse oximetry reading may be recorded for later query and/or rendered for the benefit of the user.

US Patent:

20160003624, Jan 7, 2016

Filed:

Jun 26, 2015

Appl. No.:

14/752563

Inventors:

James Tyler Frix - Calhoun GA, US

International Classification:

G01C 21/20

Abstract:

A system and method for monitoring and verifying athlete attendance in a classroom is disclosed. An exemplary embodiment defines a GPS-based fence in association with a classroom as well as defines a class start time and a class end time. GPS coordinates associated with a portable computing device (“PCD”) associated with a given athlete are received and determined to be within a range of coordinates associated with the fence. Also, a time associated with the receiving of the GPS coordinates is determined to be within a window of time comprising the class start time. Subsequently, a picture of a user is captured with a camera of the PCD. Next, from the picture the user is verified to be the given athlete. Finally, the given athlete is marked as “present” within the class.

US Patent:

20150305683, Oct 29, 2015

Filed:

Jul 9, 2015

Appl. No.:

14/795157

Inventors:

JAMES TYLER FRIX - CALHOUN GA, US
ANDREW JOHNSON - ATHENS GA, US
JAMES MITCHELL FRIX - CALHOUN GA, US
ROBERT ANDREW TAYLOR - ANDERSON SC, US

International Classification:

A61B 5/00
A61B 5/024
A61B 5/1455

Abstract:

Various embodiments of methods and systems for continuous transdermal monitoring (“CTM”) are disclosed. One exemplary method for CTM begins by monitoring an output signal from an accelerometer. The accelerometer output signal may indicate acceleration and deceleration of a body part of a user, such as the user's wrist. Based on the accelerometer output signal, it may be determined that the body part of the user has decelerated to a minimum, e.g., substantially zero. With a determination that the body part has decelerated to the minimum, e.g., substantially zero, or has not accelerated beyond the minimum, e.g., substantially zero, the method may determine a reading from a pulse oximeter associated with the accelerometer. Advantageously, the pulse oximetry reading, or a reading from other sensors associated with the accelerometer, may be optimally accurate as motion artifact may be minimized. The pulse oximetry reading may be recorded for later query and/or rendered for the benefit of the user.

US Patent:

20150094551, Apr 2, 2015

Filed:

Dec 9, 2014

Appl. No.:

14/564485

Inventors:

JAMES TYLER FRIX - CALHOUN GA, US
ANDREW JOHNSON - ATHENS GA, US
JAMES MITCHELL FRIX - CALHOUN GA, US
ROBERT ANDREW TAYLOR - ANDERSON SC, US

International Classification:

A61B 5/1455
A61B 5/11
A61B 5/0205
A61B 5/00

US Classification:

600324

Abstract:

Various embodiments of methods and systems for continuous transdermal monitoring (“CTM”) are disclosed. One exemplary embodiment of a continuous transdermal monitoring system comprises a sensor package. The sensor package may include a pulse oximetry sensor having a plurality of light detectors arranged as an array. One exemplary method for continuous transdermal monitoring begins by positioning a pulse oximetry sensor system, similar to the system described immediately above, adjacent to a target tissue segment. Then, the method continues by detecting a light reflected by the target tissue segment. Then, the method continues by transmitting a pulse oximetry reading(s), based at least in part on the light reflected by the target tissue segment, of the target tissue segment. Then, the method continues by analyzing the pulse oximetry reading(s). Then, the method continues by assessing the accuracy of the pulse oximetry reading from the first light detector relative to the pulse oximetry reading from the second light detector.

US Patent:

20150011854, Jan 8, 2015

Filed:

Jul 7, 2014

Appl. No.:

14/324963

Inventors:

JAMES TYLER FRIX - CALHOUN GA, US
ANDREW JOHNSON - ATHENS GA, US
JAMES MITCHELL FRIX - CALHOUN GA, US
ROBERT ANDREW TAYLOR - ANDERSON SC, US

International Classification:

A61B 5/145
A61B 5/024
A61B 5/11

US Classification:

600364

Abstract:

Various embodiments of methods and systems for continuous transdermal monitoring (“CTM”) are disclosed. One exemplary method for CTM begins by monitoring an output signal from an accelerometer. The accelerometer output signal may indicate acceleration and deceleration of a body part of a user, such as the user's wrist. Based on the accelerometer output signal, it may be determined that the body part of the user has decelerated to a minimum, e.g., substantially zero. With a determination that the body part has decelerated to the minimum, e.g., substantially zero, or has not accelerated beyond the minimum, e.g., substantially zero, the method may determine a reading from a pulse oximeter associated with the accelerometer. Advantageously, the pulse oximetry reading, or a reading from other sensors associated with the accelerometer, may be optimally accurate as motion artifact may be minimized. The pulse oximetry reading may be recorded for later query and/or rendered for the benefit of the user.